Sabra Healthcare SBRA FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sabra Healthcare's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sabra Healthcare's FX effect on cash?
- Sabra Healthcare (SBRA) reported FX effect on cash of -$60K in Q1 2026.
- How has Sabra Healthcare's FX effect on cash changed year-over-year?
- Sabra Healthcare's FX effect on cash decreased by 215.8% year-over-year, from -$19K to -$60K.
- What is the long-term trend for Sabra Healthcare's FX effect on cash?
- Over 3 years (2021 to 2025), Sabra Healthcare's FX effect on cash has grown at a 31.1% compound annual growth rate (CAGR), from $173.5K to $391K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.